{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:32:20Z","timestamp":1790058740286,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.peptides.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T01:01:13Z","timestamp":1497142873000},"page":"94-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"special_numbering":"C","title":["Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications"],"prefix":"10.1016","volume":"95","author":[{"given":"Yeji","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanvorleak","family":"Phat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Cheol","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2017.06.002_bib0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijbiomac.2012.06.001","article-title":"Biological activities and potential health benefits of bioactive peptides derived from marine organisms","volume":"51","author":"Ngo","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.peptides.2017.06.002_bib0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.3390\/md10050963","article-title":"Bioactive peptides and depsipeptides with anticancer potential: sources from marine animals","volume":"10","author":"Suarez-Jimenez","year":"2012","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.peptides.2017.06.002_bib0015","first-page":"27","article-title":"Marine natural products: a lead for anti-cancer","volume":"41","author":"Sarfaraj","year":"2012","journal-title":"Indian J. Geo.-Mar. Sci."},{"key":"10.1016\/j.peptides.2017.06.002_bib0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jchromb.2003.11.005","article-title":"Bioactive peptides from marine sources: pharmacological properties and isolation procedures","volume":"803","author":"Aneiros","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.peptides.2017.06.002_bib0025","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3390\/md9101840","article-title":"Antitumor peptides from marine organisms","volume":"9","author":"Zheng","year":"2011","journal-title":"Mar Drugs"},{"key":"10.1016\/j.peptides.2017.06.002_bib0030","first-page":"197","article-title":"Antitumor and cytotoxic compounds from marine organisms","volume":"1","author":"Schmitz","year":"1993","journal-title":"Mar. Biotechnol."},{"key":"10.1016\/j.peptides.2017.06.002_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/sj.leu.2402788","article-title":"Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1(flt-1) autocrine loop in human leukemia cells MOLT-4","volume":"17","author":"Broggini","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.peptides.2017.06.002_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.mrfmmm.2014.03.005","article-title":"Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment","volume":"768","author":"Beesoo","year":"2014","journal-title":"Mutat. Res."},{"issue":"9","key":"10.1016\/j.peptides.2017.06.002_bib0045","first-page":"863","article-title":"a new marine-derived compound, induces oncosis in human prostate and breast cancer cells","volume":"2","author":"Suarez","year":"2003","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.peptides.2017.06.002_bib0050","doi-asserted-by":"crossref","first-page":"9445","DOI":"10.1016\/S0040-4020(02)01224-3","article-title":"Total syntheses of lyngbyabellin A and B, potent cytotoxic lipopeptides from the marine cyanobacterium Lyngbya majuscula","volume":"58","author":"Yokokawa","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.peptides.2017.06.002_bib0055","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2202-11-154","article-title":"Antillatoxin is a sodium channel activator that displays unique efficacy in heterologously expressed rNav1.2, rNav1.4 and rNav1.5 alpha subunits","volume":"11","author":"Cao","year":"2010","journal-title":"BMC Neurosci."},{"issue":"10","key":"10.1016\/j.peptides.2017.06.002_bib0060","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/AEM.67.10.4531-4537.2001","article-title":"Evidence for the biosynthesis of bryostatins by the bacterial symbiont Candidatus Endobugula sertula of the Bryozoan Bugula neritina","volume":"67","author":"Davidson","year":"2001","journal-title":"Appl. Environ. Microb."},{"key":"10.1016\/j.peptides.2017.06.002_bib0065","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.micres.2012.06.005","article-title":"Marine actinomycetes: an ongoing source of novel bioactive metabolites","volume":"167","author":"Subramani","year":"2012","journal-title":"Microbiol. Res."},{"issue":"6","key":"10.1016\/j.peptides.2017.06.002_bib0070","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1021\/np020492o","article-title":"The guineamides, novel cyclic depsipeptides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya majuscula","volume":"66","author":"Tan","year":"2003","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.peptides.2017.06.002_bib0075","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1021\/np800617a","article-title":"cytotoxic NFkappaB inhibitors from the marine actinomycete Salinispora arenicola","volume":"72","author":"Asolkar","year":"2009","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.peptides.2017.06.002_bib0080","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.bbrc.2005.12.131","article-title":"A novel peptide sansalvamide anologue inhibits pancreatic cancer cell growth through G0\/G1 cell-cycle arrest","volume":"340","author":"Ujiki","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.peptides.2017.06.002_bib0085","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0031-9422(00)00280-6","article-title":"N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus Fusarium","volume":"55","author":"Cueto","year":"2000","journal-title":"Phytochemistry"},{"issue":"5","key":"10.1016\/j.peptides.2017.06.002_bib0090","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/CAD.0b013e32835f060d","article-title":"Synergistic effect of a novel cyclic pentadepsipeptide, neon-methylsansalvamide, and paclitaxel on human multidrug resistance cancer cell lines","volume":"24","author":"Lee","year":"2013","journal-title":"Anti-Cancer Drug"},{"issue":"49","key":"10.1016\/j.peptides.2017.06.002_bib0095","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1021\/ja992482o","article-title":"new anti-inflammatory cyclic peptides produced by a marine bacterium (Streptomyces sp.)","volume":"121","author":"Renner","year":"1999","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.peptides.2017.06.002_bib0100","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1021\/jo9814391","article-title":"Salinamides, anti-inflammatory depsipeptides from a marine Stretomycete","volume":"64","author":"Moore","year":"1999","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0105","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1007\/s00253-013-4905-y","article-title":"Marine bacterial: potential sources for compounds to overcome antibiotic resistance","volume":"97","author":"Eom","year":"2013","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"11","key":"10.1016\/j.peptides.2017.06.002_bib0110","first-page":"746","article-title":"Studies on a marine Streptomyces fradiae BW2-7 producing glycopeptide antibiotic Vancomycin effective against skin pathogens","volume":"2","author":"Ranjith","year":"2014","journal-title":"Sch. Acad. J. Biosci."},{"key":"10.1016\/j.peptides.2017.06.002_bib0115","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1021\/ja990582o","article-title":"HIV-inhibitory and cytotoxic depsipeptides from the sponges theonella mirabilis and Theonella swinhoei collected in Papua New Guinea","volume":"121","author":"Ford","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.peptides.2017.06.002_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1021\/np0002379","article-title":"Microspinosamide, a new HIV-inhibitory cyclic depsipeptide from the marine sponge Sidonops microspinosa","volume":"64","author":"Rashid","year":"2001","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.peptides.2017.06.002_bib0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/np50103a011","article-title":"Discobahamins A and B, new peptides from the Bahamian deep water marine sponge Discodermia sp","volume":"57","author":"Gunasekera","year":"1994","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.peptides.2017.06.002_bib0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1021\/jm00002a015","article-title":"Halicylindramides A-C, antifungal and cytotoxic depsipeptides from the marine sponge Halichondria cylindrata","volume":"38","author":"Li","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0135","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/md12041911","article-title":"Theonellamide G., a potent antifungal and cytotoxic bicyclic glycopeptide from the red sea marine sponge Theonella swinhoei","volume":"12","author":"Youssef","year":"2014","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.peptides.2017.06.002_bib0140","first-page":"7","article-title":"Antifungal cyclic peptides from the marine sponge Microsclederma herdmani","volume":"2","author":"Zhang","year":"2012","journal-title":"Res. Rep. Med. Chem."},{"issue":"12","key":"10.1016\/j.peptides.2017.06.002_bib0145","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/S0040-4020(01)86318-3","article-title":"Hymenamides a and b, new proline-rich cyclic heptapeptides from the okinawan marine sponge hymeniacidon sp","volume":"49","author":"Kobayashi","year":"1993","journal-title":"Tetrahedron"},{"issue":"23","key":"10.1016\/j.peptides.2017.06.002_bib0150","doi-asserted-by":"crossref","first-page":"8210","DOI":"10.1021\/jo0261909","article-title":"lipopeptides from a cryptic cyanobacterial mat containing Lyngbya confervoides","volume":"67","author":"MacMillan","year":"2002","journal-title":"J. Org. Chem."},{"issue":"2","key":"10.1016\/j.peptides.2017.06.002_bib0155","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/md8020373","article-title":"Anti-parasitic compounds from Streptomyces sp: strains isolated from Mediterranean sponges","volume":"8","author":"Pimentel-Elardo","year":"2010","journal-title":"Mar. Drugs"},{"issue":"3","key":"10.1016\/j.peptides.2017.06.002_bib0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1128\/AAC.15.3.361","article-title":"Avermectins, new family of potent anthelmintic agents: producing organism and fermentation","volume":"15","author":"Burg","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2017.06.002_bib0165","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micres.2013.07.014","article-title":"Pharmaceutically active secondary metabolites of marine actinobacteria","volume":"169","author":"Manivasagan","year":"2014","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.peptides.2017.06.002_bib0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3390\/toxins5061089","article-title":"Limited stability of microcystins in oligopeptide compositions of Microcystis aeruginosa (Cyanobacteria): implications in the definition of chemotypes","volume":"5","author":"Agha","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.peptides.2017.06.002_bib0175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0041-0101(00)00123-9","article-title":"Membrane permeabilization induced by discodermin A, anovel marine bioactive peptide","volume":"39","author":"Sato","year":"2001","journal-title":"Toxicon"},{"issue":"45","key":"10.1016\/j.peptides.2017.06.002_bib0180","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1016\/S0040-4039(01)81553-7","article-title":"Bioactive marine metabolites VI Structure elucidation of discodermin a, an antimicrobial peptide from the marine sponge Discodermia kiiensis","volume":"25","author":"Matsunaga","year":"1984","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.peptides.2017.06.002_bib0185","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.phytochem.2007.01.012","article-title":"Bioactive natural products from marine cyanobacteria for drug discovery","volume":"68","author":"Tan","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.peptides.2017.06.002_bib0190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tetlet.2007.11.031","article-title":"Stereoselective synthesis of the dolastatin units by organotrifluoroborates additions to \u03b1-amino aldehydes","volume":"49","author":"Cella","year":"2008","journal-title":"Tetrahedron Lett."},{"issue":"7","key":"10.1016\/j.peptides.2017.06.002_bib0195","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/np010049y","article-title":"Isolation of dolastatin 10 from the marine Cyanobacterium symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1","volume":"64","author":"Luesch","year":"2001","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.peptides.2017.06.002_bib0200","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1055\/s-0029-1185332","article-title":"Largamides A-C, tiglic acid-containing cyclodepsipeptides with elastase-inhibitory activity from the marine cyanobacterium Lyngbya confervoides","volume":"75","author":"Matthew","year":"2009","journal-title":"Planta Med."},{"issue":"18","key":"10.1016\/j.peptides.2017.06.002_bib0205","doi-asserted-by":"crossref","first-page":"6898","DOI":"10.1021\/jo061044e","article-title":"Largamides A-H, unusual cyclic peptides from the marine cyanobacterium Oscillatoria sp","volume":"71","author":"Plaza","year":"2006","journal-title":"J. Org. Chem."},{"issue":"31","key":"10.1016\/j.peptides.2017.06.002_bib0210","doi-asserted-by":"crossref","first-page":"8281","DOI":"10.1021\/ja00136a031","article-title":"Antillatoxin: an exceptionally ichthyotoxic cyclic lipopeptide from the tropical cyanobacterium Lyngbya majuscule","volume":"117","author":"Orjala","year":"1995","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.peptides.2017.06.002_bib0215","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0969-2126(96)00156-6","article-title":"Crystal structure of vancomycin","volume":"4","author":"Sch\u00e4fer","year":"1996","journal-title":"Structure"},{"key":"10.1016\/j.peptides.2017.06.002_bib0220","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1016\/j.bmc.2011.06.053","article-title":"Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp","volume":"19","author":"Sun","year":"2011","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0225","first-page":"42","article-title":"Targeting cellular apoptotic pathway with peptides from marine organisms","volume":"1836","author":"Zheng","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2017.06.002_bib0230","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1016\/j.bmc.2008.05.019","article-title":"Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide","volume":"16","author":"Terracciano","year":"2008","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0235","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1016\/S0040-4020(99)00410-X","article-title":"The absolute stereochemistry of Kahalalide F","volume":"55","author":"Goetz","year":"1999","journal-title":"Tetrahedron"},{"issue":"3","key":"10.1016\/j.peptides.2017.06.002_bib0240","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1006\/bbrc.1995.2580","article-title":"Didemnin B. induces cell death by apoptosis: the fastest induction of apoptosis ever described","volume":"215","author":"Grubb","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.peptides.2017.06.002_bib0245","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.peptides.2017.06.002_bib0250","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1016\/S0040-4039(99)00393-7","article-title":"Sansalvamide: a new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium","volume":"40","author":"Belofsky","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.peptides.2017.06.002_bib0255","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.foodchem.2010.11.023","article-title":"A new cytotoxic cyclic pentadepsipeptide, neo-N-methylsansalvamide produced by Fusarium solani KCCM90040, isolated from potato","volume":"126","author":"Song","year":"2011","journal-title":"Food Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0260","first-page":"09","article-title":"Natural sources as potential anti-cancer agents: a review","volume":"3","author":"Bhanot","year":"2011","journal-title":"Int. J. Phytomedicine"},{"key":"10.1016\/j.peptides.2017.06.002_bib0265","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.copbio.2010.09.018","article-title":"Bryostatins: biological context and biotechnological prospects","volume":"21","author":"Trindade-Silva","year":"2010","journal-title":"Curr. Opin. Biotechnol."},{"issue":"49","key":"10.1016\/j.peptides.2017.06.002_bib0270","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1002\/anie.201000728","article-title":"Salinosporamide natural products: potent 20S proteasome inhibitors as promising cancer chemotherapeutics","volume":"49","author":"Gulder","year":"2010","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.peptides.2017.06.002_bib0275","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.tet.2012.05.103","article-title":"Stereoselective functionalization of pyrrolidinone moiety towards the synthesis of salinosporamide A","volume":"68","author":"Barbion","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.peptides.2017.06.002_bib0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrd2487","article-title":"Drug development from marine natural products","volume":"8","author":"Molinski","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.peptides.2017.06.002_bib0285","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.1016\/S0021-9258(17)44880-0","article-title":"Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and Vinca alkaloid sites","volume":"265","author":"Bai","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.peptides.2017.06.002_bib0290","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1128\/AAC.42.11.2961","article-title":"Specific activities of Dolastalin 10 and peptide derivatives against Cryptococcus neoformans","volume":"42","author":"Pettit","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.peptides.2017.06.002_bib0295","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.antiviral.2010.03.009","article-title":"Marine compounds and their antiviral activities","volume":"86","author":"Yahuhara-Bell","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.peptides.2017.06.002_bib0300","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/bjc.1998.570","article-title":"In vitro activity of aplidine, a new marine-derived anti-cancer compound, on freshly explanted clonogenic human tumour cells and haematopoietic precursor cells","volume":"78","author":"Depenbrock","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.peptides.2017.06.002_bib0305","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-3835(96)04151-1","article-title":"Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates","volume":"102","author":"Urdiales","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.peptides.2017.06.002_bib0310","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/bmc.286","article-title":"Liquid chromatographic assay for the cyclic depsipeptide aplidine, a new marine antitumor drug, in whole blood using derivatization with trans-4\u2032-hydrazino-2-stilbazole","volume":"18","author":"Sparidans","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.peptides.2017.06.002_bib0315","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/CDLI.7.6.947-952.2000","article-title":"Jasplakinolide induces apoptosis in various transformed cell lines by a caspase-3-like protease-dependent pathway","volume":"7","author":"Odaka","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.peptides.2017.06.002_bib0320","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00018-002-8515-6","article-title":"Induction of apoptosis and CD10\/neutral endopeptidase expression by jaspamide in HL-60 line cells","volume":"59","author":"Cioca","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.peptides.2017.06.002_bib0325","first-page":"167","article-title":"Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy","volume":"1805","author":"Li","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.peptides.2017.06.002_bib0330","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3762\/bjoc.10.101","article-title":"Consecutive isocyanide-based multicomponent reactions: synthesis of cyclic pentadepsipeptoids","volume":"10","author":"Barreto","year":"2014","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0335","doi-asserted-by":"crossref","first-page":"11723","DOI":"10.1016\/j.tet.2005.09.036","article-title":"Isolation and structure of five lyngbyabellin derivatives from a papua new guinea collection of the marine cyanobacterium lyngbya majuscula","volume":"61","author":"Han","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.peptides.2017.06.002_bib0340","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/annonc\/mdg443","article-title":"Progress in the development and acquisition of anticancer agents from marine sources","volume":"14","author":"Amador","year":"2003","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.peptides.2017.06.002_bib0345","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1096\/fj.09-143388","article-title":"Antimicrobial peptides from marine invertebrates as a new frontier for microbial infection control","volume":"24","author":"Otero-Gonz\u00e1lez","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.peptides.2017.06.002_bib0350","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00253-007-1221-4","article-title":"Optimization of culture conditions and scale-up to pilot and plant scales for vancomycin production by Amycolatopsis orientalis","volume":"77","author":"Jung","year":"2007","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.peptides.2017.06.002_bib0355","doi-asserted-by":"crossref","first-page":"30883","DOI":"10.1074\/jbc.M113.493767","article-title":"Structural basis of mycobacterial inhibition by cyclomarin A","volume":"288","author":"Vasudevan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2017.06.002_bib0360","doi-asserted-by":"crossref","first-page":"e02451","DOI":"10.7554\/eLife.02451","article-title":"Transcription inhibition by the depsipeptide antibiotic salinamide A","volume":"3","author":"Degen","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.peptides.2017.06.002_bib0365","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/md8030810","article-title":"Cyclodepsipeptides from marine sponges: natural agents for drug research","volume":"8","author":"Andavan","year":"2010","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.peptides.2017.06.002_bib0370","doi-asserted-by":"crossref","first-page":"8529","DOI":"10.1016\/j.tet.2011.08.100","article-title":"Papuamides E and F, cytotoxic depsipeptides from the marine sponge Melophlus sp","volume":"67","author":"Prasad","year":"2011","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.peptides.2017.06.002_bib0375","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10637-014-0185-3","article-title":"The marine natural product microsclerodermin A is a novel inhibitor of the nuclear factor kappa B and induces apoptosis in pancreatic cancer cells","volume":"33","author":"Guzm\u00e1n","year":"2015","journal-title":"Invest. New Drugs"},{"issue":"2","key":"10.1016\/j.peptides.2017.06.002_bib0380","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/np9600309","article-title":"Halicylindramides D and E, antifungal peptides from the marine sponge Halichondria cylindrata","volume":"59","author":"Li","year":"1996","journal-title":"J. Nat. Prod."},{"issue":"11","key":"10.1016\/j.peptides.2017.06.002_bib0385","first-page":"4205","article-title":"Phase II. study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma","volume":"6","author":"Vaishampayan","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.peptides.2017.06.002_bib0390","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2010.02.005","article-title":"The odyssey of marine pharmaceuticals: a current pipeline perspective","volume":"31","author":"Mayer","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"9","key":"10.1016\/j.peptides.2017.06.002_bib0395","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1349-7006.2003.tb01526.x","article-title":"Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo","volume":"94","author":"Natsume","year":"2003","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.peptides.2017.06.002_bib0400","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/CAD.0000000000000183","article-title":"Cyclic depsipeptides as potential cancer therapeutics","volume":"26","author":"Kitagaki","year":"2015","journal-title":"Anti-Cancer Drug"},{"key":"10.1016\/j.peptides.2017.06.002_bib0405","first-page":"1854","article-title":"Phase I clinical and pharmacokinetic study of Kahalalide F in Patients with advance androgen refractory prostate cancer","volume":"11","author":"Rademaker-Lakhai","year":"2005","journal-title":"Chin. Cancer Res."},{"issue":"4","key":"10.1016\/j.peptides.2017.06.002_bib0410","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/1078-0432.CCR-07-4366","article-title":"Phase I clinical and pharmacokinetic study of kahalalide F administered weekly as a 1-hour infusion to patients with advanced solid tumors","volume":"14","author":"Pardo","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.peptides.2017.06.002_bib0415","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00280-013-2170-5","article-title":"Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors","volume":"72","author":"Salazar","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"10.1016\/j.peptides.2017.06.002_bib0420","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejca.2008.12.005","article-title":"Phase II study of weekly Kahalalide F in patients with advanced malignant melanoma","volume":"45","author":"Mart\u00edn-Algarra","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.peptides.2017.06.002_bib0425","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/bjc.1995.356","article-title":"A phase I trial of bryostatin 1 in patients with advanced malignancies using a hour intravenous infusion","volume":"72","author":"Jayson","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.peptides.2017.06.002_bib0430","first-page":"399","article-title":"First total synthesis and biological screening of hymenamide E","volume":"56","author":"Dahiya","year":"2006","journal-title":"Acta Pharm."},{"key":"10.1016\/j.peptides.2017.06.002_bib0435","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.mi.38.100184.002011","article-title":"The structure and mode of action of glycopeptides antibiotics of the vancomycin group","volume":"38","author":"Barna","year":"1984","journal-title":"Annu. Rev. Microbiol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117302139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978117302139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:08:04Z","timestamp":1659089284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978117302139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":87,"alternative-id":["S0196978117302139"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2017.06.002","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural diversity of marine cyclic peptides and their molecular mechanisms for anticancer, antibacterial, antifungal, and other clinical applications","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}